ECCT/16/06/02 |
A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings |
07/08/2012 |
Paclitaxel, Bleomycin,Vincristine and Etoposide |
Advanced AIDS-KS |
; Chemical: Paclitaxel, Bleomycin,Vincristine and Etoposide |
The National Institute of Allergy and Infectious Diseases (NIAID) The National Cancer Institute (NCI) National Institute of Dental Craniofacial Research (NIDCR) Contact: Dr. Kevin Cain |
Kisumu CRS Contact: P.O BOX 1578-40100 |
Kenya, Uganda, South Africa, Malawi, Peru and Zimbabwe |
ECCT/15/11/03 |
A Phase 3 Open‚ÄêLabel Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of the Combination of Moxifloxacin plus PA‚Äê824 plus Pyrazinamide after 4 and 6 months of Treatment in Adult Subjects with Drug‚ÄêSensitive Smear‚ÄêPositive Pulmonary Tuberculosis and after 6 months of Treatment in Adult Subjects with Multi‚ÄêDrug Resistant, Smear‚ÄêPositive Pulmonary Tuberculosis |
14/04/2014 |
PA-824 |
Tuberculosis |
Biologicals; Toxoid; Chemical: Avelox |
Global Alliance for TB Drug Development Contact: Dr. Daniel E. Everitt, MD |
KEMRICDC Contact: 1578-40100 |
Kenya, Tanzania, Uganda, South Africa, Mozambique, Zambia, USA, Peru, Thailand, Phillipines, China, Russia, Ukraine, Malaysia, Brazil, Haiti |